Physician's Weekly19h
Prostate-Specific Antigen Density Threshold for Optimizing Biopsy Decisions
The following is a summary of “Optimal PSA density threshold for prostate biopsy in benign prostatic obstruction patients ...
The Manila Times2d
Fusion Biopsy Market to Hit US$0.91 Billion by 2029 with 7.1% CAGR | MarketsandMarkets™.
The global fusion biopsy market, valued at US$0.61 billion in 2023, is forecasted to grow at a robust CAGR of 7.1%, reaching ...
Cambridge Independent5d
How Lucida Medical’s AI-powered software spotted man’s prostate cancer that a radiologist couldn’t detect
Mark Hinton, CTO at Lucida Medical, said: “Pi is medical device software that is CE-approved for use in clinics. We developed ...
Healthline5d
How Many Types of Prostate Cancer Are There?
Adenocarcinoma grows in the tissue of the prostate gland, but other types of cancer can also start in the prostate or spread ...
Minimally invasive prostate cancer treatment shows success in first patient
Bill Faulkner had long approached prostate cancer testing with skepticism. For almost a decade, the 73-year-old had avoided ...
Oncology Nurse Advisor6d
MRI Cannot Replace Confirmatory Biopsy in Prostate Cancer Active Surveillance
Investigators assessed whether MRI alone can identify all cases of Gleason grade group 2 or higher disease in patients on prostate cancer active surveillance.